HISTORY AND SOME RESULTS OF HIV GENOTYPING IN RUSSIA
https://doi.org/10.22328/2077-9828-2015-7-4-7-16
Abstract
The article is devoted to the topical issue of the status of HIV genotyping methodology in clinical practice in Russia. The data about the history of the introduction of this type of laboratory studies, as well as the current state of the laboratory and advisory basis for the detection of HIV drug resistance mutations. The article presents the results of a sample survey conducted in 9 AIDS centers in Russia on the issues of compliance of the appointment and interpretation of HIV genotyping to the recommended algorithm in practice. The conclusion about the need to restructure the existing system of HIV drug resistance laboratory analysis toward the centralization of research, the implementation of quality control and evidence-based results systematization, as well as the raise of education level of medical specialists.
About the Author
M. R. Bobkova
FSBI «N.F.Gamaleya Federal Research Center of Epidemiology and Microbiology», of the Ministry of Health of Russia
Russian Federation
Russian Federation
References
1. Казеннова Е.В., Васильев А.В., Коровина Г.И. Сравнительный анализ систем генотипирования ViroSeq и Trugene для выявления мутаций лекарственной устойчивости и полиморфизма вариантов ВИЧ-1, доминирующих в России // Клиническая лабораторная диагностика.- 2009.- Т. 12.- С. 46-51.
2. Определение чувствительности вируса иммунодефицита человека к лекарственным препаратам: Методические рекомендации (Утв. 6 августа 2007 г. № 5956-РХ / Миздравсоцразвития России, 2007.- URL: http://www.lawmix.ru/expertlaw/78583 (дата обращения 21.07.2015 г.).
3. Надзор за распространением штаммов ВИЧ, резистентных к антиретровирусным препаратам. Методические рекомендации. МР 3.1.5.0075/1-13. Роспотребнадзор, 2013.- URL: http://standartgost.ru/g/%D0%9C%D0%A0_3.1.0075/1-13 (дата обращения 23.07.2015 г.).
4. Bennett D.E., Bertagnolio S., Sutherland D. The World Health Organization’s global strategy for prevention and assessment of HIV drug resistance // Antivir. Ther.- 2008.- Vol. 13, Suppl. 2.- Р. 1-13.
5. Bennett D.E., Myatt M., Bertagnolio S. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment // Antivir. Ther.- 2008.- Vol. 13, Suppl. 2.3.- Р. 25-36.
6. Jordan M.R., Bennett D.E., Bertagnolio S. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites// Antivir Ther.- 2008.- Vol. 13, Suppl. 2.- Р. 15-23.
7. ВИЧ-инфекция и СПИД. Национальное руководство / Под ред. В.В.Покровского.- М.: Гэотар-Медиа, 2013.- 608 с.
8. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents / Department of Health and Human Services. Available from.- URL: http://www.aidsinfo.nih.gov/contentfiles/lvguidelines/adultandado-lescentgl.pdf (дата обращения 23.07.2015 г.).
9. Vandamme A.M., Camacho R.J., Ceccherini-Silberstein F European recommendations for the clinical use of HIV drug resistance testing: 2011 update // AIDS Rev. - 2011.- Vol. 13, № 2- Р. 77-108.
10. Writing G., Williams I., Churchill D. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 // HIV Med.- 2014.- Vol. 15, Suppl. 1.- Р. 1-85.
11. Thompson M.A., Aberg J.A., Hoy J.F. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel // JAMA.- 2012.- Vol. 308, № 4.- Р. 387-402.
12. Бобкова М.Р. Лекарственная устойчивость ВИЧ.- М.: Человек, 2014.- 288 с.
13. Corbett A. Sheffield C. Key Pharmacologic Principles and Drug-Drug Interactions in HIV Patient Care. 2014; Available from.- URL: https://www.inpractice.com/Textbooks/HIV/Antiretroviral_Therapy/ch19_pt2_DrugDrug_Interactions.aspx (дата обращения 15.07.2015 г.).
14. Iniesta-Navalon C., Franco-Miguel J.J., Gascon-Canovas J.J. Identification of potential clinically significant drug interactions in HIV-infected patients: a comprehensive therapeutic approach // HIV Med.- 2015.- Vol. 16, № 5.- Р. 273-279.
15. Tang M.W., Liu T.F. Shafer R.W. The HIVdb system for HIV-1 genotypic resistance interpretation// Intervirology.- 2012.- Vol. 55, № 2.- Р. 98-101.
16. Bertagnolio S., Derdelinckx I., Parker M. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy // Antivir. Ther.- 2008.- Vol. 13, Suppl. 2.- Р. 49-57.
17. Land S., Zhou J., Cunningham P. Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa // J. Int. AIDS Soc.- 2013.- Vol. 16.- Р. 1-10.
18. Parkin N., Bremer J. Bertagnolio S. Genotyping external quality assurance in the World Health Organization HIV drug resistance laboratory network during 2007-2010 // Clin. Infect. Dis.- 2012.- Vol. 54, Suppl. 4.- Р. 266-272.
19. Delong A.K., Wu M., Bennett D. Sequence quality analysis tool for HIV type 1 protease and reverse transcriptase // AIDS Res. Hum. Retroviruses.- 2012.- Vol. 28, № 8.- Р. 894-901.
20. Xu S., Li J., Bao Z. Development and evaluation of a national reference panel of HIV-1 protease and reverse transcriptase drug-resistance mutations for HIV-1 genotypic resistance assays in China // Mol. Diagn. Ther.- 2010.- Vol. 14, № 1.- Р. 31-41.
21. Казеннова Е.В., Лаповок И.А., Лага В.Ю. Естественные полиморфизмы гена pol варианта ВИЧ-1 IDU-A // ВИЧ-инфекция и иммуносупрессии.- 2012.- Т. 4, № 4.- С. 44-51.
22. Kolomeets A.N., Varghese V., Lemey P. A uniquely prevalent nonnucleoside reverse transcriptase inhibitor resistance mutation in Russian subtype A HIV-1 viruses // AIDS.- 2014.- Vol. 28, № 17.- Р. 1-8.
23. Maiga A.I., Descamps D., Morand-Joubert L. Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naive patients infected with non-B HIV-1 subtypes // Antimicrob Agents Chemother.- 2010.- Vol. 54, № 2.- Р. 728-733.
24. Santos A.F., Tebit D.M., Lalonde M.S. Effect of natural polymorphisms in the HIV-1 CRF02_AG protease on protease inhibitor hypersusceptibility // Antimicrob Agents Chemother.- 2012.- Vol. 56, № 5.- Р. 2719-2725.
Review
For citations:
Bobkova M.R. HISTORY AND SOME RESULTS OF HIV GENOTYPING IN RUSSIA. HIV Infection and Immunosuppressive Disorders. 2015;7(4):7-16. (In Russ.) https://doi.org/10.22328/2077-9828-2015-7-4-7-16
Views:
1012
.png)
Email this article 